NDC 70710-1775-05 - atorvastatin calcium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70710-1775
- Requested NDC
- 70710-1775-05
- Package NDCs from labels
- 70710-1775-9, 70710-1775-5, 70710-1775-0, 70710-1775-05
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2025-10-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| atorvastatin calcium - A-S Medication Solutions | A-S Medication Solutions | 2025-10-21 | HUMAN PRESCRIPTION DRUG LABEL |
| atorvastatin calcium - A-S Medication Solutions | A-S Medication Solutions | 2025-10-21 | HUMAN PRESCRIPTION DRUG LABEL |
| atorvastatin calcium - Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | Zydus Pharmaceuticals Limited | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | Zydus Pharmaceuticals Limited | 2025-05-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70710-1775-0 | atorvastatin calcium | 1000 in 1 BOTTLE | TABLET | 1000 | 3 | |
| 70710-1775-5 | atorvastatin calcium | 500 in 1 BOTTLE | TABLET | 500 | 3 | |
| 70710-1775-9 | atorvastatin calcium | 90 in 1 BOTTLE | TABLET | 90 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70710-1775 | ATORVASTATIN CALCIUM TABLET [ZYDUS PHARMACEUTICALS USA INC.] | 2 | Current NDC, 3 package rows | 20240618_55ad4a90-d177-4cce-b7ec-cb75067f6c14.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70710-1775-0 | EA - Each | 70710-1775 | a646afd8-ac06-42ed-8811-b90381c8edfb | 1 | 2024-08-12 |
| 70710-1775-9 | EA - Each | 70710-1775 | e45202fb-a6b5-4ef4-b5d8-2e053d62c668 | 1 | 2024-08-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vitrexyl | FOLIC ACID | PureTek Corporation | ae064a9e-daba-fa86-e053-2a95a90a16a7 | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Vitranol Fe | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | b81daf17-430b-6ba2-e053-2a95a90a768b | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Vitrexate | FOLIC ACID | PureTek Corporation | b34fee43-bea9-45b7-e053-2a95a90aad4d | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Vitrexate FE | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | b3637def-a701-673a-e053-2995a90a02d5 | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Venexa | FOLIC ACID | PureTek Corporation | ba130779-cdfd-086d-e053-2a95a90a2590 | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Venexa FE | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | ba142128-21c4-4204-e053-2a95a90ae0d7 | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Ribotin-E | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfcd-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Ventrixyl Fe | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | c7a626ec-88ec-d899-e053-2a95a90ab0ba | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Zintrexyl-C | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfca-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| EARACHE DROPS | BELLADONNA LEAF, CALCIUM CARBONATE, CHAMOMILE, LYCOPODIUM CLAVATUM SPORE, ANEMONE PATENS, AND SULFUR | Hyland's Inc. | 9b18453e-e338-4b8e-9856-85aca8c46ee1 | 2022-12-12 | Warnings | H0G9379FGK |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | Proficient Rx LP | a1b22973-cb9a-473e-a240-112b3e84e97c | 2022-12-01 | Warnings, Adverse reactions | 617311 48A5M73Z4Q |
| Refresh Digital PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | 97e83e68-6374-4df4-93f6-d707fc32748d | 2022-11-28 | Warnings | 6OZP39ZG8H |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | Proficient Rx LP | 44f0df8b-6069-4941-87e9-2c57c8dfddfa | 2022-11-28 | Warnings, Adverse reactions | 617311 617310 |
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | 6OZP39ZG8H |
| OSTEOBIOS | CALCITONIN HUMAN - CALCIUM CARBONATE - CALCIUM FLUORIDE - CALCIUM PHOSPHATE - ISOLEUCINE - LEUCINE - LYSINE - METHIONINE - PHENYLALANINE - SUS SCROFA BONE - SUS SCROFA PARATHYROID GLAND - THREONINE - TRYPTOPHAN - VALINE - | Guna spa | 1b8c8c83-1a46-4c0a-b883-e7dce781c5d1 | 2022-11-14 | Warnings | H0G9379FGK |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | Proficient Rx LP | 957feff4-5005-4eea-bbe2-7232be65b0eb | 2022-10-01 | Warnings, Adverse reactions | 259255 |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | Proficient Rx LP | a34d3c72-ce91-47c7-86a1-f32caaed2c47 | 2022-10-01 | Warnings, Adverse reactions | 259255 48A5M73Z4Q |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | ebd0839e-2e1d-4e0e-986c-19f1f5c76358 | 2022-09-15 | Warnings | 6OZP39ZG8H |
| injoy heartburn relief | FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE | L. Perrigo Company | aca1b9e5-a35e-4eef-b55a-4189cd1b2a02 | 2022-09-07 | Warnings | H0G9379FGK |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | 6OZP39ZG8H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.